title: Successful intravenous thrombolysis in acute ischaemic stroke in a patient on rivaroxaban treatment.
authors.affiliation: Michal M. Kawiorski, MD, Department of Neurology, University Hospital Ramon y Cajal, Ctra. de Colmenar Km. 9,100, 28034 Madrid, Spain, Tel.: +34 605304096, Fax: +34 913369016, E-mail: mmkawiorski@gmail.com.
authors.forename: M M
authors.initials: MM
authors.lastname: Kawiorski
authors.forename: A
authors.initials: A
authors.lastname: Alonso-Canovas
authors.forename: A
authors.initials: A
authors.lastname: de Felipe Mimbrera
authors.forename: S
authors.initials: S
authors.lastname: Sainz de la Maza
authors.forename: R
authors.initials: R
authors.lastname: Alvarez-Velasco
authors.forename: B
authors.initials: B
authors.lastname: Zarza
authors.forename: J
authors.initials: J
authors.lastname: Masjuan
mesh_terms: D061605:Administration, Intravenous; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001157:Arterial Occlusive Diseases / Q000175:diagnosis / Q000188:drug therapy*; D000075202:Contraindications; D057510:Endovascular Procedures; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D007511:Ischemia / Q000175:diagnosis / Q000188:drug therapy*; D020768:Middle Cerebral Artery / Q000473:pathology; D009025:Morpholines / Q000008:administration & dosage* / Q000009:adverse effects; D000069552:Rivaroxaban; D020521:Stroke / Q000175:diagnosis* / Q000188:drug therapy; D013876:Thiophenes / Q000008:administration & dosage* / Q000009:adverse effects; D015912:Thrombolytic Therapy / Q000379:methods; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban; D010959:Tissue Plasminogen Activator